321 related articles for article (PubMed ID: 25886744)
1. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.
Yang B; Zhou X; Lan C
BMC Gastroenterol; 2015 Apr; 15():43. PubMed ID: 25886744
[TBL] [Abstract][Full Text] [Related]
2. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model.
Chen B; Zhu S; Du L; He H; Kim JJ; Dai N
Scand J Gastroenterol; 2017 Oct; 52(10):1065-1071. PubMed ID: 28679338
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
[TBL] [Abstract][Full Text] [Related]
4. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
[TBL] [Abstract][Full Text] [Related]
5. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.
Chen J; Zhang Y; Deng Z
BMC Gastroenterol; 2012 Jul; 12():91. PubMed ID: 22816602
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome.
Long Y; Wang W; Wang H; Hao L; Qian W; Hou X
J Gastroenterol Hepatol; 2012 May; 27(5):935-44. PubMed ID: 22141367
[TBL] [Abstract][Full Text] [Related]
7. Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model.
Hong KB; Seo H; Lee JS; Park Y
BMC Complement Altern Med; 2019 Jul; 19(1):195. PubMed ID: 31366385
[TBL] [Abstract][Full Text] [Related]
8. Adenosine 2A receptor contributes to the facilitation of post-infectious irritable bowel syndrome by γδ T cells
Dong LW; Chen YY; Chen CC; Ma ZC; Fu J; Huang BL; Liu FJ; Liang DC; Sun DM; Lan C
World J Gastroenterol; 2023 Mar; 29(9):1475-1491. PubMed ID: 36998428
[TBL] [Abstract][Full Text] [Related]
9. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N
Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome.
Keating C; Pelegrin P; Martínez CM; Grundy D
J Immunol; 2011 Aug; 187(3):1467-74. PubMed ID: 21697458
[TBL] [Abstract][Full Text] [Related]
11. Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.
Dong LW; Ma ZC; Fu J; Huang BL; Liu FJ; Sun D; Lan C
World J Gastroenterol; 2022 Jul; 28(25):2955-2967. PubMed ID: 35978875
[TBL] [Abstract][Full Text] [Related]
12. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.
Chen BR; Du LJ; He HQ; Kim JJ; Zhao Y; Zhang YW; Luo L; Dai N
World J Gastroenterol; 2017 Dec; 23(47):8321-8333. PubMed ID: 29307992
[TBL] [Abstract][Full Text] [Related]
13. Alteration of cholinergic and peptidergic neurotransmitters in rat ileum induced by acute stress following transient intestinal infection is mast cell dependent.
Leng YX; Wei YY; Chen H; Zhou SP; Yang YL; Duan LP
Chin Med J (Engl); 2010 Jan; 123(2):227-33. PubMed ID: 20137376
[TBL] [Abstract][Full Text] [Related]
14. Preinduction of heat shock protein 70 protects mice against post-infection irritable bowel syndrome via NF-κB and NOS/NO signaling pathways.
Zhou X; Dong L; Yang B; He Z; Chen Y; Deng T; Huang B; Lan C
Amino Acids; 2015 Dec; 47(12):2635-45. PubMed ID: 26215736
[TBL] [Abstract][Full Text] [Related]
15. [Altered expression of intestinal cytokines in development of postinfectious irritable bowel syndrome mouse model].
Long YQ; Tong JJ; Qian W; Hou XH
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(34):2415-9. PubMed ID: 21092513
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
Du C; Peng L; Kou G; Wang P; Lu L; Li Y
Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
[TBL] [Abstract][Full Text] [Related]
17.
Zhao Q; Yang WR; Wang XH; Li GQ; Xu LQ; Cui X; Liu Y; Zuo XL
World J Gastroenterol; 2019 Sep; 25(36):5469-5482. PubMed ID: 31576093
[TBL] [Abstract][Full Text] [Related]
18. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
Bennet SM; Polster A; Törnblom H; Isaksson S; Capronnier S; Tessier A; Le Nevé B; Simrén M; Öhman L
Am J Gastroenterol; 2016 Aug; 111(8):1165-76. PubMed ID: 27272011
[TBL] [Abstract][Full Text] [Related]
19. Serum and colonic mucosal immune markers in irritable bowel syndrome.
Chang L; Adeyemo M; Karagiannides I; Videlock EJ; Bowe C; Shih W; Presson AP; Yuan PQ; Cortina G; Gong H; Singh S; Licudine A; Mayer M; Tache Y; Pothoulakis C; Mayer EA
Am J Gastroenterol; 2012 Feb; 107(2):262-72. PubMed ID: 22158028
[TBL] [Abstract][Full Text] [Related]
20. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction.
Bercík P; Wang L; Verdú EF; Mao YK; Blennerhassett P; Khan WI; Kean I; Tougas G; Collins SM
Gastroenterology; 2004 Jul; 127(1):179-87. PubMed ID: 15236184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
